Louisiana 2022 2022 Regular Session

Louisiana House Bill HB190 Comm Sub / Analysis

                    SSHB190 2709 5487
HOUSE SUMMARY OF SENATE AMENDMENTS
HB 190	2022 Regular Session Travis Johnson
MEDICAL MARIJUANA:  Authorizes certain nurse practitioners to recommend medical
marijuana to patients
Synopsis of Senate Amendments
1.Authorizes medical psychologists to recommend medical marijuana to patients.
Digest of Bill as Finally Passed by Senate
Present law authorizes licensed physicians to recommend marijuana for therapeutic use,
known commonly as "medical marijuana", by patients clinically diagnosed as suffering from
any debilitating medical condition defined in present law.  Proposed law revises present law
to authorize medical psychologists and licensed nurse practitioners who have prescriptive
authority, in addition to licensed physicians, to recommend medical marijuana to patients.
Proposed law replaces "physician" with the term "authorized clinician" in present law relative
to medical marijuana.  Provides that all of the following licensed health professionals are
authorized to recommend medical marijuana to patients and shall be deemed "authorized
clinicians":
(1)Any physician licensed by and in good standing with the La. State Board of Medical
Examiners to practice medicine in this state.
(2)Any nurse practitioner licensed by and in good standing with the La. State Board of
Nursing to practice advanced practice registered nursing in this state and who has
prescriptive authority conferred by the La. State Board of Nursing.
(3)Any medical psychologist licensed by and in good standing with the La. State Board
of Medical Examiners to practice medical psychology in this state.
Proposed law, to conform relevant provisions of present law with proposed law, revises
references to health professionals who may recommend medical marijuana in the following
areas of present law:
(1)Law providing immunity from prosecution for possession of marijuana (R.S.
40:966(F)).
(2)Law providing for a data system for the collection and analysis of clinical
information associated with use of medical marijuana by patients (R.S. 40:1168.1 et
seq.).
(Amends R.S. 40:966(F)(1), (7), and (8)(a), 1046(A)(1), (2)(a)(xviii), (xxii), and (b), (3), (4),
(5)(b), (6), and (C)(1), 1168.2(2)-(5), and 1168.3(A)(1)(b)(iii), (iv), and (2)(b); Adds R.S.
40:1046(B))
Page 1 of 1